Saturday, 14 November 2026
M
Meridian Globe
Live briefing
[Comment] Is chemotherapy still needed in all patients with mismatch repair-deficient advanced or recurrent endometrial cancer?— 柳叶刀 Lancet[Comment] The overlooked role of CMV in pneumonia in infants with HIV— 柳叶刀 Lancet[Comment] Empirical tuberculosis treatment in infants living with HIV: missed opportunities and ways to improve outcomes— 柳叶刀 Lancet[Comment] Offline: Anthony Fauci comes to London— 柳叶刀 Lancet[World Report] WHO's next Director-General— 柳叶刀 Lancet[World Report] Access to medicines: innovations not reaching those in need— 柳叶刀 Lancet[Perspectives] Lalitha Regi and Regi George: strengthening community health— 柳叶刀 Lancet[Perspectives] Critical thinking about assisted dying— 柳叶刀 Lancet[Comment] Is chemotherapy still needed in all patients with mismatch repair-deficient advanced or recurrent endometrial cancer?— 柳叶刀 Lancet[Comment] The overlooked role of CMV in pneumonia in infants with HIV— 柳叶刀 Lancet[Comment] Empirical tuberculosis treatment in infants living with HIV: missed opportunities and ways to improve outcomes— 柳叶刀 Lancet[Comment] Offline: Anthony Fauci comes to London— 柳叶刀 Lancet[World Report] WHO's next Director-General— 柳叶刀 Lancet[World Report] Access to medicines: innovations not reaching those in need— 柳叶刀 Lancet[Perspectives] Lalitha Regi and Regi George: strengthening community health— 柳叶刀 Lancet[Perspectives] Critical thinking about assisted dying— 柳叶刀 Lancet

Cholesterol efflux capacity as an indicator of HDL dysfunction across the metabolic syndrome spectrum in a South Indian cohort

Source Nature 医学研究16h ago
Summary

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Health
Region
Global
Language
English
Item ID
health-074b9027

Comments 0 comments

No comments yet. Be the first.

Cholesterol efflux capacity as an indicator of HDL dysfunction across the metabolic syndrome spectrum in a South Indian cohort · Meridian Globe